Table: begin end state 1 11 cytoplasmic 12 30 transmembrane 31 42 non-cytoplasmic 43 64 transmembrane 65 75 cytoplasmic 76 97 transmembrane 98 147 non-cytoplasmic 148 167 transmembrane 168 187 cytoplasmic 188 208 transmembrane 209 219 non-cytoplasmic 220 245 transmembrane 246 292 cytoplasmic 293 319 transmembrane 320 321 non-cytoplasmic 322 339 transmembrane 340 349 cytoplasmic 350 373 transmembrane 374 379 non-cytoplasmic 380 401 transmembrane 402 441 cytoplasmic
Input: >BPHYT_RS16825 FitnessBrowser__BFirm:BPHYT_RS16825 MLKFFNSLFGRVVIALVAGIVVGAVFPHFAQSLRPLGDGFLKLIKMVIGPIVFCVVVSGM AHAGDLRKVGRVGLKAVIYFEVMTTIALVIGAILAYVTRPGVGMNIDLHSLDPASLSTYT EHAKSLKDTAGFLLKIIPDTAINAFATGDILQILVFSVLFGSALSLLGNKAQRVSSLIDE LSQVFFRVMGFIIKLAPLGVLGAIAFTTGTYGVESLKQLGMLVLVFYLSCFVFVVVVLGV VMRLAGFSIFKLIRYLREELSIVLGTASSDAVLPQIMRKLEWMGVKDSTVGLVIPTGYSF NLDGFSIYLTLAVIFIAQATNTPLSVHDLIVVVLVSLVTSKGAHGIPGSAIVILAATLSA IPAIPVLGLVLILPVDWFVGIARALTNLIGNCVATVVVAVWENDIDRARAHRVLNRDEAL RYVPAGEDAEPAAAGEHAPAV
Or try the official Phobius web server, which has a different display
Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server